target upgrad unit state go sg websit
upsid tp
nc chang
although larg acquisit segment frequent initi
result sale dis-synergi gener prove highli
success long term think frutarom acquisit
differ although still see need improv qualiti
visibl key perform metric encourag normalis
demand trend strong progress integr limit
impact briberi incid consid current discount
peer ev earn multipl deep-valu opportun reiter
buy rate increas tp
need improv qualiti prior frutarom acquisit
under-perform peer organ growth previou ten year think
partli due
long abstin acquisit
adjac also note frequent high volatil growth earn vs
peer exampl headwind destock tast organ declin
yoy seen peer furthermor investor focu
 space seem mainli organ growth ifr metric ebitda net
debt/ebitda visibl metric poor
frutarom becom fix although frutarom big riski acquisit
prove difficult integr initi expect seem excel
strateg fit significantli increas iff exposur fast-grow adjac
group underrepres argu initi headwind frutarom
integr line histor trend soon fade quest big
headach givaudan initi see interest opportun transfer element
frutarom extrem
focus
organis henc appreci decid appli frutarom incent
system entir group signific oper synergi alreadi
identifi deliveri alreadi exce initi expect
valuat accord manag volum trend seem much
encourag vs disappoint risk briberi investig
frutarom oper russia ukrain virtual remov reduc
valuat discount appli iff ev earn multipl
keep conserv sotp use earn
transit year point fair valu vs
societ general sg seek busi compani cover research report result investor awar
sg may conflict interest could affect object report investor consid report singl factor
make invest decis pleas appendix end report analyst certif
result report novemb close us top line prove
weak organ revenu growth yoy incl fx-driven price excl vs
givaudan symris profit resili howev adj ebit margin
excl amortis yoy result adj ep excl amortis came
bang line expect manag reduc guidanc adj ep
excl amortis low end rang far consensu
expect
rate includ fx-base price underperform
growth outperform profit
adj ebitda compani report full quarterli
result margin recoveri driven pass-through input
cost inflat integr synergi givaudan
time compani highlight deliveri integr synergi progress
extrem well increas synergi target second time year
previous initi target manag said optimist
would abl over-deliv vs total target without give
detail discuss detail think realist
impact emerg market currenc organ growth exclud
includ givaudan symris
also expect gradual normalis input cost price support
currenc neutral growth bridg current perform growth target exclud fx
trend octob novemb order book visibl five week seem improv
significantli organ revenu growth run rate increas mid-singl digit
although base effect recent integr headwind seem set weigh growth
base effect russia/ukrain briberi investig citrasourc
natur colour expect kick mid-year manag optimist
growth rate start improv gradual
manag reiter long-term target organ growth yoy adj ep
compound-annual-growth-rate understand manag team aim approach target
model organ growth yoy plu fx adj ep
growth yoy estim yoy organ growth adj ep
declin yoy still group long-term target
accord manag sever potenti near-term catalyst
group reach import mileston investig irregular payment russia
ukrain frutarom legaci addit irregular found region
secondari investig high-risk region rais concern replac
key manag layer region expect materi financi impact
incid sale impact group total accord manag impair
asset due briberi investig under-perform frutarom sinc
acquisit virtual growth vs prior run rate mid-singl digit year-end unlik
result despit rather disappoint oper trend ytd reduc guidanc
share continu stage signific recoveri support low expect
progress synergi result newsflow synergi briberi
investig think must also short-cov day
flavour fragranc sector overview although histor lag european peer qualiti valuat discount
price-to-earnings ev metric seem justifi us
exposur fast-grow indi brand sale
exposur fast-grow adjac market sale
emerg market exposur sale
product categori sale
symris product categori sale
givaudan product categori sale
iff acquisit frutarom certainli got bumpi start think givaudan
acquisit integr quest tell encourag tale
frutarom quest certainli fulli compar term activ integr
challeng differ analysi deal thrown interest
parallel firstli surpris current slowdown organ growth frutarom
underli pre-acquisit mid-single-digit run-rat averag accord
difficult verifi given frutarom made frequent acquisit organ growth
flat yoy think revers reflect
internalis extern sale client overlap case frutarom competitor stop
buy citru raw materi citrasourc acquir current
unfavour market environ pocket weak natur colour pass-through
decreas input cost weigh organ growth russia/ukrain briberi investig
hamper demand region compound on-going headwind strong input cost
inflat view none pressur game-chang
signific acquisit frequent result temporari headwind
secondli think histori iff side acquir quest late around
peak cycl period rise margin pressur due input cost inflat
givaudan found weak spot year nonetheless quest becom true
long-term success stori givaudan point financi market start
look beyond quest integr market challeng earli turn givaudan
share price perform posit well group financi metric recov
see similar scope earli rebound iff share price anticip success
frutarom integr process said given frutarom aggress acquisit strategi
recent year integr process still like rais unexpect challeng
howev think materi issu frutarom and/or commerci
process would alreadi made public inde way
manag handl briberi issu russia ukrain indic us would
shi away integr challeng
givaudan quest acquisit combin raw materi price inflat result disappoint share-pric
perform sale dis-synergi integr setback margin contract put stock signific pressur
share price chf per announc quest acqusit ev/ebitda feb mandatori convert slow organ growth yoy organ growth revers posit ebitdamargin trend margin declin yoy cost inflat start weigh profit
iff share price drop acquisit announc level due integr headwind result profit
warn august achiev import mileston russia/ ukrain briberi investig much better
improv trade october-novemb help close gap
acquisit
ambiti synergi cost save target might even exceed
prior acquir frutarom vigor integr acquisit inde
frutarom profil like hold compani manag expand portfolio
fast-grow independ satellit compani acquir compani like
associ subsidiari
ad frutarom oper manufactur facil creativ centr
applic laboratori differ countri frutarom gain addit
manufactur facil addit d/applic laboratori global includ
mani countri alreadi oper region overlap fact
frutarom significantli higher number product unit laboratori despit
less half size indic signific scope rationalis
think iff manag plan fulli integr frutarom legaci acquisit
network process certainli come opportun signific cost could
taken addit sale synergi like tap current manag guid
increment sale impli compound-annual-growth-rate
howev entail heavi legwork involv plant closur identifi plant
closur initi redund henc challeng look
manag guid integr save run rate less
frutarom sale addit across iff legaci oper
sale may look ambiti seem justifi
given frutarom vast product laboratori network geograph overlap
note follow acquisit quest givaudan announc deliv
estim synergi amount quest sale
frutarom went aggress acquisit spree
iff legaci busi margin alreadi close turn point
see major posit differ givaudan-quest iff-frutarom deal
input cost inflat relat recur temporari margin pressur start build
integr quest time around input cost inflat even stronger
back amplifi string unplan supplier plant shutdown basf
chines indian supplier began therefor conclud
alreadi peak alreadi see sign start eas almost
compani guid low- mid-single-digit input cost inflat would
good
due delay pass-through input cost inflat price increas take time due
contract time need negoti and/or reformul recip iff ebitda margin
contract howev histor industri consist
prove abl restor margin via price increas think time differ
least almost entir industri flag margin improv notabl
along improv profit work capit free cash flow
gener benefit
exposur non-discretionari structur grow nutrit
cosmet end-market view fragranc flavour defens sector
financi crisi saw two consecut quarter neg underli growth
still deliv posit organ growth annualis basi even
trough year
subsequ worst-cas recess scenario includ underli top-lin
growth even meaning bottom-lin growth input cost tend weaken
recess integr benefit cost save effort lend support
short think sweet spot continu benefit new structur
growth trend top exist health well natur sustain theme
exampl recent success plant-bas patti produc beyond
meat imposs food creat new growth opportun contrast
fresh meat virtual plant-bas patti use natur flavour given current urbanis
trend one hand desir healthier lifestyl global see
plenti innov growth opportun compani
top- bottom-lin growth set acceler
chart show histor struggl deliv top-lin target
keep peer sale earn also compar volatil
think mainli reflect lack diversif adjac high-growth market
start expand adjac market via bolt-on acquisit
absent market almost decad also relat iff histor lack
exposur fast-grow region local white-label produc limit natur
organ growth perform iff compound-annual-growth-rate volatil peer
ad frutarom portfolio significantli strengthen presenc
exact dynam growth segment henc view sale dis-synergi weak
isol market pocket natur colour russian/ukrain overcom start
outperform peer
report sale growth givaudan hit fx effect symris benefit
diana acquisit set benefit frutarom integr
valuat discount us compani rare
rare exampl us compani trade valuat discount european peer
stock current trade discount givaudan symris ev
see sever explan discount
past struggl keep pace peer term top-lin growth
coupl rel high top- bottom-lin volatil
taken rel technical/chem approach busi past
communication-wis symris givaudan croda mainli focus
consum market trend innov last least growth opportun
reposit
consum good sector
consequ earn valuat premium vs consum good
european special ingredi compani grow faster profit
custom thank broad custom base
product portfolio includ exposur smaller indi brand local region
player emerg market etc short shown littl lumpi
term clients/brand overreli singl client/seg
think integr frutarom progress catch even outperform
european peer term growth profit thu least narrow discount
weak profil us term may anoth headwind
note anoth specif us stock market may often simpli overlook
north american investor compar small compani big diversifi
market place lack critic number domest high-qual peer contrast
europ wider small- mid-cap special ingredi segment signific
includ croda symris givaudan kerri dsm chr hansen novozym addit
bigger group small- mid-cap special chemic name offer defens
characterist combin high return henc premium valuat includ
like fuch petrolub victrex em chemi
benchmark european peer test pass
think iff busi model good match european peer especi post
frutarom saw close gap symris term portfolio diversif fast-
grow adjac exposur fast-grow region local player
signific acquisit grown market size current frutarom market
cap around half henc visibl perspect see
uniqu opportun narrow even entir close valuat gap vs european
peer back success integr frutarom next two three year
broad peer group valuat point fair valu per share
datastream base close price novemb
european peer close frutarom integr
use stock-market comparison valu due somewhat higher histor top-and
bottom-lin volatil compar compani appli discount
shown tabl howev reduc discount previous
first sign normalis organ growth remov biggest
singl risk name asset impair risk relat briberi investig
russian ukrainian oper due disappoint perform frutarom
sinc acquisit describ begin report
mani altern perform metric make number difficult
make extens non-gaap adjust ebitda ebit ep free cash flow net
debt/ebitda result high number metric altern although adjust
meant improv visibl underli busi make compar
european peer also creat seriou challeng term consist number
valuat consensu
asid strip non-recur cost relat restructur integr major
acquisit adj ebit adj ep also exclud amortis relat
histor acquisit moreov net debt/ebitda calcul base definit
agre lender disclos ident adjust
appli adjust ebitda ebitda us-gaap account adjust ep
besid absolut sale number underli sale growth rate adjust ep ex
amortis profit indic provid market annual basi
addit adjust net debt/ebitda defin lender /sale
anoth non-gaap metric featur manag mid-term guidanc
net debt/ebitda guidanc base non-gaap metric despit disclosur
adjust criteria iff websit criteria fulli transpar
base combin result net debt adjust ebitda non-gaap metric non-gaap disclosur ir iff com
given european compani partial follow iff practic
recent disclos acquisition-rel amortis calcul compar
adjust ep number excl amortis shown overview tabl page
howev multipl way account amortis acquir intang
asset recip brand patent client list includ acquisition-rel
amortis adjust number
valu minor
valu financi invest
depreci amortis
chang work capit
flow oper activ
flow invest activ
flow financ activ
net chang cash result cf
intang
share basic year end/outstand
share price average hist yr current
report complet nov cet
follow name research analyst herebi certifi certifi view express research report accur reflect
person view subject secur issuer ii part compens
relat directli indirectli specif recommend view express report thoma swoboda
analyst author research employ sg affili locat includ limit pari london new york
hong kong tokyo bangalor frankfurt madrid milan geneva seoul warsaw moscow
valu per share base sotp model appli valuat discount european peer group
ev/ebitda earn multipl due histor slower top line growth higher earn volatil
downsid materi setback integr frutarom lead sustain turnov profit growth potenti loss ie intang
asset write off potenti impact tp sharp input cost inflat histor weak short-term price power price increas
take month potenti impact tp return oper issu like malodour issu asia fda mandat product
recal potenti impact tp
sg equiti research rate month period
buy absolut total sharehold return forecast
month period
hold absolut total sharehold return forecast
month period
sell absolut total sharehold return forecast
plu forecast cash dividend incom includ incom
special dividend paid month period rate
determin rang describ time
initi coverag chang rate subject limit
manag discret time rate may fall outsid
rang market price movement and/or
short term volatil trade pattern interim deviat
specifi rang permit becom subject
review research manag
sector weight definit month period
sector weight assign sg equiti research
strategist distinct separ sg equiti research
analyst rate base relev
overweight sector expect outperform relev broad
market benchmark next month
neutral sector expect perform in-lin relev
broad market benchmark next month
underweight sector expect under-perform relev
broad market benchmark next month
prefer least prefer stock select
cover analyst base individu analyst coverag
univers sg equiti research strategist
equiti rate dispers relationship
updat
price inform includ report market close unless otherwis state
disclaim sourc inform exclus properti morgan stanley capit intern inc without
prior written permiss inform intellectu properti may reproduc redissemin
use creat financi product includ indic inform provid basi user assum entir
risk use made inform affili third parti involv relat comput compil
inform herebi expressli disclaim warranti origin accuraci complet merchant fit particular
purpos respect inform without limit forego event shall affili
third parti involv relat comput compil inform liabil damag kind morgan
stanley capit intern index servic mark affili similar languag may
provid approv advanc
